CFA UK Review All articles
Market Analysis

Probability Before Premium: A UK Analyst's Takeover Announcement Checklist

CFA UK Review
Probability Before Premium: A UK Analyst's Takeover Announcement Checklist

UK public takeover announcements arrive as headlines: a percentage premium to the undisturbed share price, a cash or share consideration mix, a board recommendation, and a strategic rationale. For the equity analyst, however, the headline is only the first data point. A bid is a conditional corporate action, not a completed transaction. The useful analytical discipline is to separate the offer price from the probability that shareholders will actually receive it.

That distinction matters for valuation, event-driven positioning and fundamental read-across. A 35% premium on a low-probability bid is not equivalent to a 20% premium on a transaction with financing confirmed, irrevocables covering a meaningful stake and a clear regulatory path. CFA UK Review readers should treat the announcement as a disclosure bundle to be tested, not a price to be accepted.

Rule 2.7 is a commitment, not a completion

A Rule 2.7 announcement under the Takeover Code is a firm intention to make an offer. It is a serious moment in the process, but it is not the offer document and it is not completion. The announcement should identify the offeror, the terms, the conditions, the financing arrangements and any irrevocable commitments. The offer document normally follows within 28 days, subject to Panel consent, and it is there that the conditionality and mechanics become more granular.

Analysts should therefore read the Rule 2.7 announcement for what it commits the bidder to do, and read the offer document for what could still prevent completion. The gap between the two documents is often where the market's initial enthusiasm meets legal, regulatory and timetable reality.

Financing certainty: follow the confirmation, then the cash

For cash offers, the Rule 2.7 announcement should include a cash confirmation from the offeror's financial adviser. That confirmation is an important signal, but it is not a guarantee that the transaction will complete. The analyst should ask what sits behind it: committed debt facilities, their expiry dates, conditions precedent, and whether the financing package depends on the same regulatory approvals as the offer itself.

For share-for-share offers, the headline value is not fixed. The offer value moves with the bidder's share price and the exchange ratio. If the consideration includes a mix of cash and shares, the analyst should model the value at announcement, at the current bidder price, and under a plausible range of bidder prices at completion. A headline premium calculated on the first day of the offer period may look very different by the time shareholders vote.

Conditions: map the approval stack

Conditions are where completion probability is built or eroded. UK public deals commonly require competition clearance, sector regulatory approval, shareholder approval and, for a scheme of arrangement, court sanction. The analyst should list each condition, identify who controls it, and estimate the likely timetable.

Competition review may involve a Phase 1 or Phase 2 reference to the Competition and Markets Authority. National security review under the National Security and Investment Act 2021 can add a separate approval track. For regulated sectors, change-of-control approvals from the FCA, the PRA or another sector regulator may be required. These are not box-ticking items: they can be timetable events with remedies, information requests and long-stop dates.

The key analytical question is whether the conditions are largely within the parties' control or whether they depend on third-party discretion. A deal with a single, well-precedented antitrust clearance is different from one with multiple overlapping approvals and a tight long-stop date.

Irrevocables: count quality, not quantity

Irrevocable commitments are often cited in announcement coverage as evidence of support. The analyst should look beyond the percentage. Who has given the commitment? Is it from directors, institutional shareholders or a strategic holder? Is it conditional on regulatory approval or on the offer document containing certain terms? Does it cover shares that would be voted at a scheme meeting, and does it materially affect the threshold?

A high headline irrevocable percentage may be less reassuring if it is concentrated in a holder with a strategic agenda or if the commitment falls away in specified circumstances. Conversely, a smaller but unconditional commitment from a long-term institutional holder can be a more useful signal of deal momentum.

Timetable risk is a risk factor

Takeover timetables are not administrative detail. They are part of the investment case. The 28-day offer document period, the offer period itself, scheme meeting dates, court hearings and long-stop dates all create windows in which the bid can fail, lapse or be delayed. A delay is not neutral: it ties up capital, extends exposure to market moves and can change the value of share consideration.

Analysts should also watch for statements about the bidder's financing expiry relative to the expected completion date. A financing package that matures before the long-stop date is a warning sign. So is a regulatory timetable that depends on a reference period the parties cannot control.

A first-read checklist

From headline to probability

The analytical task is not to dismiss the premium. It is to price the probability. A UK takeover announcement is a value event only when the offer price is matched against financing certainty, conditionality and timetable risk. For analysts, the disciplined response is to update the probability-weighted valuation first and the headline narrative second. That is how a noisy signal becomes a usable investment judgement.

All Articles

Related Articles

The Adviser Has Changed: A UK Analyst's Governance Read-Across

The Adviser Has Changed: A UK Analyst's Governance Read-Across

Silence as Signal: A Due-Diligence Protocol for UK Companies That Stop Guiding

Silence as Signal: A Due-Diligence Protocol for UK Companies That Stop Guiding

Coverage Continuity: A UK Analyst's Response When Sell-Side Research Fades

Coverage Continuity: A UK Analyst's Response When Sell-Side Research Fades